Listened to more music last year? You’re not alone.

The global music industry surpassed 4 trillion streams in 2023, a new single-year record, Luminate’s 2023 Year-End Report found.

Global streams were also up 34% from last year, reflective of an increasingly international music marketplace.

Stateside, three genres saw the biggest growth in 2023: country (23.7%), Latin (which encompasses all Latin musical genres, up 24.1%) and world (a catchall that includes J-pop, K-pop and Afrobeats, up 26.2%.)

As for the Taylor Swift of it all: Time’s 2023 Person of the Year made up 1.79% of the U.S. market, Luminate found, accounting for 1 in every 78 U.S. on-demand audio streams.

Her dominance is reflected in Luminate’s 2023 top albums chart, where Swift accounts for five of the top 10 albums in the U.S.

ADHD drug prescriptions surged during pandemic

Prescriptions for ADHD treatments surged among adults during the COVID-19 pandemic, helping to fuel lingering shortages that frustrate parents and doctors.

New prescriptions for stimulants used to treat the condition jumped for young adults and women during a two-year window after the pandemic hit in March 2020, according to a study published Wednesday in JAMA Psychiatry.

Prescriptions also soared for nonstimulant treatments for adults of all ages, the U.S. Food and Drug Administration researchers found.

Attention-deficit/hyperactivity disorder is one of the most common developmental disorders in children, particularly boys. The use of drugs like Adderall to treat it climbed in general during the pandemic.

Rising use of ADHD treatments compounded with manufacturing problems triggered an Adderall shortage that started more than a year ago. Doctors and patients say supply problems for several treatments haven’t let up.